Thomas Marron, MD, PhD, Professor of Medicine, Hematology and Oncology, Director, Early Phase Trials Unit, Hematology and Oncology, Professor of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai Presents:  "Cancer Immunotherapy in 2024:  Progress Towards Curing the Incurable"